Figure 2.

Effect of concurrent antidiabetes drug treatment on patients treated with ranolazine reaching an A1C goal of ≤7%. Patients with a history of diabetes who were hyperglycemic at randomization (A1C >7%) were grouped by drug treatment. These patients were reexamined at 4 months and categorized as responders if A1C was ≤7%. OR for hyperglycemic patients in each group to reach an A1C ≤7% was calculated using a logistics analysis model (SAS software, Cary, NC). Data are plotted as OR (95% CI). Ins, insulin.